help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on September 25, 2002, doi:10.1164/rccm.200206-606OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200206-606OCv1
166/12/1563    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hubbard, R. B.
Right arrow Articles by Tattersfield, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hubbard, R. B.
Right arrow Articles by Tattersfield, A. E.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1563-1566, (2002)
© 2002 American Thoracic Society

Original Article

Inhaled Corticosteroids and Hip Fracture

A Population-based Case–Control Study

Richard B. Hubbard, Chris J. P. Smith, Liam Smeeth, Tim W. Harrison and Anne E. Tattersfield

Division of Respiratory Medicine, University of Nottingham, Nottingham City Hospital, Nottingham; and London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom

Correspondence and requests for reprints should be addressed to Richard Hubbard, D.M., University of Nottingham, Division of Respiratory Medicine, Clinical Sciences Building, Nottingham City Hospital, Nottingham NG5 1PB, United Kingdom. E-mail: richard.hubbard{at}nottingham.ac.uk

There is accumulating evidence that the use of inhaled corticosteroids is associated with a dose-related reduction in bone mineral density. Whether this translates to an increase in fracture is unclear. We have used the General Practice Research Database to perform a case–control analysis, including 16,341 cases of hip fracture (mean age of 79 years, 79% female, median period prescribing data 2.7 years) and 29,889 control subjects, individually matched by age, sex, and general practice. Data for all prescriptions for corticosteroids and for potential confounders, including other drug use and comorbid illnesses, were extracted, and the impact of inhaled corticosteroid exposure was analyzed using conditional logistic regression. The risk of hip fracture was associated with exposure to inhaled corticosteroids with an odds ratio of 1.26 (95% confidence interval, 1.17 to 1.36). This odds ratio was reduced after adjusting the model for annual courses of oral corticosteroids, the only confounder of note (OR 1.19; 95% CI, 1.10 to 1.28). There was a dose–response relationship between inhaled corticosteroid use and hip fracture even after adjusting for the annual number of courses of oral corticosteroids (p trend = 0.007). In older subjects, the recent use of inhaled corticosteroids is associated with a dose-related increase in hip fracture.

Key Words: inhaled corticosteroids • oral corticosteroids • hip fracture • case–control study




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suissa
Medications to Modify Lung Function Decline in Chronic Obstructive Pulmonary Disease: Some Hopeful Signs
Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 322 - 323.
[Full Text] [PDF]

Home page
 PediatricsHome page
H. W. Kelly, M. L. Van Natta, R. A. Covar, J. Tonascia, R. P. Green, R. C. Strunk, and for the CAMP Research Group
Effect of Long-term Corticosteroid Use on Bone Mineral Density in Children: A Prospective Longitudinal Assessment in the Childhood Asthma Management Program (CAMP) Study
Pediatrics, July 1, 2008; 122(1): e53 - e61.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. R. Chapman
Safer Inhaled Corticosteroid Therapy for Asthma
Pediatrics, January 1, 2008; 121(1): 179 - 180.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. G. Camp and S. M. Goring
Gender and the Diagnosis, Management, and Surveillance of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 686 - 691.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
M. Pujades-Rodriguez, C.J.P. Smith, and R.B. Hubbard
Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease
QJM, August 1, 2007; 100(8): 509 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Masoli, M. Weatherall, S. Holt, P. Shirtcliffe, and R. Beasley
Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis
Eur. Respir. J., November 1, 2006; 28(5): 960 - 967.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Hubbard, A. Tattersfield, C. Smith, J. West, L. Smeeth, and A. Fletcher
Use of inhaled corticosteroids and the risk of fracture.
Chest, October 1, 2006; 130(4): 1082 - 1088.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
G. Gartlehner, R. A. Hansen, S. S. Carson, and K. N. Lohr
Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes
Ann. Fam. Med, May 1, 2006; 4(3): 253 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. de Vries, T. P. van Staa, M. S. G. M. Bracke, C. Cooper, H. G. M. Leufkens, and J-W. J. Lammers
Severity of obstructive airway disease and risk of osteoporotic fracture
Eur. Respir. J., May 1, 2005; 25(5): 879 - 884.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. B. Johannes, G. A. Schneider, T. J. Dube, T. D. Alfredson, K. J. Davis, and A. M. Walker
The Risk of Nonvertebral Fracture Related to Inhaled Corticosteroid Exposure Among Adults With Chronic Respiratory Disease
Chest, January 1, 2005; 127(1): 89 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. D. Scanlon, J. E. Connett, R. A. Wise, D. P. Tashkin, T. Madhok, M. Skeans, P. C. Carpenter, W. C. Bailey, A. S. Buist, M. Eichenhorn, et al.
Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1302 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. E. Tattersfield, T. W. Harrison, R. B. Hubbard, and K. Mortimer
Safety of Inhaled Corticosteroids
Proceedings of the ATS, November 1, 2004; 1(3): 171 - 175.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
I A Campbell, J G Douglas, R M Francis, R J Prescott, and D M Reid
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
Thorax, September 1, 2004; 59(9): 761 - 768.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. G. Schlienger, S. S. Jick, and C. R. Meier
Inhaled Corticosteroids and the Risk of Fractures in Children and Adolescents
Pediatrics, August 1, 2004; 114(2): 469 - 473.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. D. Sin, J. Man, H. Sharpe, W. Q. Gan, and S. F. P. Man
Pharmacological Management to Reduce Exacerbations in Adults With Asthma: A Systematic Review and Meta-analysis
JAMA, July 21, 2004; 292(3): 367 - 376.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Gluck and G. Colice
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Chest, May 1, 2004; 125(5): 1859 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. A. Lee and K. B. Weiss
Fracture Risk Associated with Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 855 - 859.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
T Card, J West, R Hubbard, and R F A Logan
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study
Gut, February 1, 2004; 53(2): 251 - 255.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
C Nielson and D Wingete
Intensive care and invasive ventilation in the elderly patient, implications of chronic lung disease and comorbidities
Chronic Respiratory Disease, January 1, 2004; 1(1): 43 - 54.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suissa, M. Baltzan, R. Kremer, and P. Ernst
Inhaled and Nasal Corticosteroid Use and the Risk of Fracture
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 83 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
L Smeeth, M Boulis, R Hubbard, and A E Fletcher
A population based case-control study of cataract and inhaled corticosteroids
Br. J. Ophthalmol., October 1, 2003; 87(10): 1247 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. P. van Staa, H. G. M. Leufkens, C. Cooper, R. B. Hubbard, T. W. Harrison, A. E. Tattersfield, and L. Smeeth
Inhaled corticosteroids and hip fracture: Disease or drugs?
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 128 - 129.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 319 - 332.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society